Brief: Cereno Scientific's Phase II Clinical Trial Postponed Due To COVID-19

Cereno Scientific AB

30/03/2020 08:25

March 30 (Reuters) - Cereno Scientific AB  CRNOSb.TE :
    * CERENO SCIENTIFIC'S PHASE II CLINICAL TRIAL POSTPONED DUE
TO
COVID-19
    * DUE TO GLOBAL SPREAD OF SARS-COV-2 VIRUS CERENO SCIENTIFIC
ANNOUNCES THAT COMPANY WILL POSTPONE PLANNED PHASE II CLINICAL
TRIAL WITH COMPANY'S LEAD COMPOUND CS1. START OF STUDY WAS
PREVIOUSLY PLANNED FOR MID-YEAR 2020.
    * IS ADJUSTING PLANNED ACTIVITIES TO START BY END OF YEAR,
BUT IS
PREPARED FOR FURTHER ADJUSTMENTS IF NEEDED, DUE TO UNCERTAINTY
OF FURTHER DEVELOPMENT OF PANDEMIC
    * THERE ARE NO POSSIBILITIES TO START PHASE II STUDY IN
ELECTIVE
ORTHOPEDIC SURGERY, AS PLANNED KNEE JOINT SURGERY IS DOWN
PRIORITIZED IN HOSPITALS FOR BENEFIT OF EFFECTIVE CARE TO
COVID-19 INFECTED PATIENTS

Source text for Eikon:  ID:nWkr7kZCzC 
Further company coverage:  CRNOSb.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))